Document:

Summary Sheet of Director Fees and Executive Officer Compensation

 Exhibit 10.1 
  
 SUMMARY SHEET OF DIRECTOR FEES AND EXECUTIVE OFFICER COMPENSATION 
  
 I. Director Compensation 
  
 As compensation for their service as directors of The Providence Service Corporation (the
“Company”), each non-employee member of the Board of Directors (the “Board”) receives a $10,000 annual stipend, except for the Audit Committee Chair who receives a $28,800 annual stipend. Payment of the annual stipends is made on
a quarterly basis following each quarter of service. Additionally, each non-employee member of the Board receives $3,500 for each Board meeting attended in person, $1,000 for each telephonic meeting of the Board participated in, and $1,000 for each
committee meeting attended or participated in by telephone of which such non-employee member of the Board is a member that is not held the same day as a Board meeting, except that the Audit Committee Chair receives $2,500 for each Audit Committee
meeting attended or participated in by telephone that is not held the same day as Board meeting. 
  
 In addition, each non-employee member then serving on the first business day of each January receives a ten year option to purchase 10,000 shares of the Company’s common stock under the Company’s 2003 Stock
Option Plan with an exercise price equal to the closing market price of the Company’s common stock on the date of grant. Such options will vest in three equal installments on each of the first, second and third anniversary of the date of grant.

  
 II. Executive Compensation 
  
 Base Salaries 
  
 The following table sets forth current base salaries of the Company’s CEO and each of
the executive officers who were named in the Summary Compensation Table in the Company’s definitive proxy statement filed with the SEC on April 20, 2005 (the “Named Executive Officers”). 
  

				
	 Name

	  	Base Salary

	 Fletcher Jay McCusker
	  	$	250,000
	 William Boyd Dover
	  	 	190,000
	 Michael N. Deitch
	  	 	195,000
	 Fred D. Furman
	  	 	195,000
	 Craig A. Norris
	  	 	200,000

  
 Participation in
Stock Option Plan and Other Arrangements 
  

 1 

 The Named Executive Officers are also eligible to: 
  

	 	•	 	Participate in the Company’s 2003 Stock Option Plan; 

  

	 	•	 	Participate in certain group life, health, medical and other non-cash benefits generally available to all salaried employees; and 

  

	 	•	 	Participate in certain health and dental benefits for their family, which are not available to all salaried employees. 

  

 2Fifth Supplemental Indenture, Dated as of March 11,2005

 EXHIBIT 4.10 
  
 FIFTH SUPPLEMENTAL INDENTURE 
  

This Fifth Supplemental Indenture (this “Fifth Supplemental Indenture”) dated as of March 11, 2005, by and between PacifiCare
Health Systems, Inc., a Delaware corporation (the “Company”); PacifiCare Health Plan Administrators, Inc., an Indiana corporation, PacifiCare eHoldings, Inc., a California corporation, MEDeMORPHUS Healthcare Solutions, Inc.
(formerly known as RxConnect, Inc.), a California corporation, SeniorCo, Inc., a Delaware corporation, Rx Solutions, Inc., a California corporation, PacifiCare Behavioral Health, Inc., a Delaware corporation, Secure Horizons USA, Inc., a California
corporation, PacifiCare of Arizona, Inc., an Arizona corporation, PacifiCare Oklahoma, Inc., an Oklahoma corporation, PacifiCare Southwest Operations, Inc., a Delaware corporation, and American Medical Security Group, Inc, a Wisconsin corporation
(collectively, the “Existing Subsidiary Guarantors”); and Nurse Healthline, Inc, a Wisconsin corporation, and Continental Plan Services, Inc., a Wisconsin corporation (the “Additional Subsidiary
Guarantors”); and U.S. Bank National Association, a national banking association, as successor to State Street Bank and Trust Company of California, N.A., as trustee under the Indenture referred to below (the
“Trustee”). Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture referred to below. 
  
 RECITALS 
  
 WHEREAS, the Company and the Subsidiary Guarantors executed and delivered to the Trustee an Indenture, dated as of May 21, 2002, as
supplemented by the First Supplemental Indenture dated as of September 15, 2003, as supplemented by the Second Supplemental Indenture dated as of November 19, 2003, as supplemented by the Third Supplemental Indenture dated as of January 14, 2004
(the “Indenture”) and as supplemented by the Fourth Supplemental Indenture dated as of December 13, 2004 providing for the issuance of an aggregate principal amount of $500,000,000 of 10 3/4% Senior Notes due 2009 (the
“Notes”); 
  
 WHEREAS,
Section 4.07 of the Indenture provides that the Company will cause each Restricted Subsidiary (other than the PHPA Subsidiary Guarantors) that would be permitted to guarantee payment of the Notes without obtaining the approval of governmental or
regulatory agencies or authorities or incurring regulatory restrictions on the operations of such subsidiary to execute and deliver a supplemental indenture to the Indenture providing for an unsubordinated Guarantee of payment of the Notes by each
such Restricted Subsidiary; 
  
 WHEREAS, the
Additional Subsidiary Guarantors are Restricted Subsidiaries of the Company under Section 4.07 of the Indenture; 
  
 WHEREAS, pursuant to Section 9.01 of the Indenture, the Trustee, the Company, the Existing Subsidiary Guarantors and the Additional
Subsidiary Guarantors are authorized, without notice to or the consent of any Holder, to execute and deliver this Fifth Supplemental Indenture to cause the Additional Subsidiary Guarantors to Guarantee the Notes to comply with Section 4.07 of the
Indenture; and 
  
 WHEREAS, the Company, the
Trustee, the Existing Subsidiary Guarantors and the Additional Subsidiary Guarantors desire to enter into this Fifth Supplemental Indenture to provide for such Note Guarantees as contemplated by Section 4.07 of the Indenture. 

 AGREEMENT 
  

NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration,
the receipt of which is hereby acknowledged, the Company, the Existing Subsidiary Guarantors, the Additional Subsidiary Guarantors and the Trustee mutually covenant and agree as follows: 
  
 1. Creation of Note Guarantee. The Additional Subsidiary Guarantors hereby agree, jointly and severally with all
other Subsidiary Guarantors, to Guarantee the Notes and the performance of the Company’s obligations under the Notes and the Indenture in accordance with the terms and provisions of Article Ten of the Indenture. The Additional Subsidiary
Guarantors shall be bound by, and entitled to the benefits of, all other applicable terms and provisions of the Indenture as a Subsidiary Guarantor, including the provisions relating to the release of the Note Guarantees in certain circumstances.

  
 2. Ratification of Indenture; Supplemental Indenture Part
of Indenture. Except as expressly amended hereby, the Indenture is in all respects ratified and confirmed and all the terms, conditions and provisions thereof shall remain in full force and effect. This Fifth Supplemental Indenture shall form a
part of the Indenture for all purposes, and every holder of the Notes heretofore or hereafter authenticated and delivered shall be bound hereby. 
  
 3. Governing Law. THIS FIFTH SUPPLEMENTAL INDENTURE SHALL BE GOVERNED BY THE LAWS OF THE STATE OF NEW YORK. 
  
 4. Trustee Makes No Representation. The Trustee makes no
representation as to the validity or adequacy of this Fifth Supplemental Indenture. 
  
 5. Counterparts. The parties may sign any number of copies of this Fifth Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. 
  
 6. Effect of Headings. The Section headings herein are for convenience
only and shall not effect the construction thereof. 

 IN WITNESS WHEREOF, the parties hereto
have caused this Fifth Supplemental Indenture to be duly executed as of the date first written above. 
  

			
	PACIFICARE HEALTH SYSTEMS, INC.
		
	By:	 	/s/    MICHAEL A. MONTEVIDEO
	Name:	 	Michael A. Montevideo
	Title:	 	Vice President and Treasurer
	
	 PACIFICARE HEALTH PLAN
 ADMINISTRATORS, INC.

		
	By:	 	/s/    MICHAEL A. MONTEVIDEO
	Name:	 	Michael A. Montevideo
	Title:	 	Treasurer
	
	PACIFICARE EHOLDINGS, INC.
		
	By:	 	/s/    MICHAEL A. MONTEVIDEO
	Name:	 	Michael A. Montevideo
	Title:	 	Treasurer
	
	SENIORCO, INC.
		
	By:	 	/s/    MICHAEL A. MONTEVIDEO
	Name:	 	Michael A. Montevideo
	Title:	 	Treasurer
	
	RXSOLUTIONS, INC.
		
	By:	 	/s/    MICHAEL A. MONTEVIDEO
	Name:	 	Michael A. Montevideo
	Title:	 	Treasurer
	
	PACIFICARE BEHAVIORAL HEALTH, INC.
		
	By:	 	/s/    MICHAEL A. MONTEVIDEO
	Name:	 	Michael A. Montevideo
	Title:	 	Assistant Treasurer
	
	SECUREHORIZONS USA, INC.
		
	By:	 	/s/    MICHAEL A. MONTEVIDEO
	Name:	 	Michael A. Montevideo
	Title:	 	Treasurer

			
	PACIFICARE OF ARIZONA, INC.
		
	By:	 	/s/    MICHAEL A. MONTEVIDEO
	Name:	 	Michael A. Montevideo
	Title:	 	Treasurer
	
	PACIFICARE OF OKLAHOMA, INC.
		
	By:	 	/s/    MICHAEL A. MONTEVIDEO
	Name:	 	Michael A. Montevideo
	Title:	 	Assistant Treasurer
	
	PACIFICARE SOUTHWEST OPERATIONS, INC.
		
	By:	 	/s/    MICHAEL A. MONTEVIDEO
	Name:	 	Michael A. Montevideo
	Title:	 	Vice President and Treasurer
	
	AMERICAN MEDICAL SECURITY GROUP, INC.
		
	By:	 	/s/    MICHAEL A. MONTEVIDEO
	Name:	 	Michael A. Montevideo
	Title:	 	Treasurer
	
	NURSE HEALTHLINE, INC.
		
	By:	 	/s/    MICHAEL A. MONTEVIDEO
	Name:	 	Michael A. Montevideo
	Title:	 	Treasurer
	
	CONTINENTAL PLAN SERVICES, INC.
		
	By:	 	/s/    MICHAEL A. MONTEVIDEO
	Name:	 	Michael A. Montevideo
	Title:	 	Treasurer
	
	U.S. BANK NATIONAL ASSOCIATION
		
	By:	 	/s/    PAULA OSWALD
	Name:	 	Paula Oswald
	Title:	 	Vice PresidentForm of Restricted Stock Agreement

 Exhibit 10.1 
  
 RESTRICTED STOCK AGREEMENT 
  
 THIS RESTRICTED STOCK AGREEMENT (this “Agreement”) is made as of
            , 200   between Symmetry Medical Inc., a Delaware corporation (the “Company”), and
                     (“Grantee”). 
  
 WHEREAS, the Grantee is an employee of the Company; and 
  
 WHEREAS, the grant of the shares of restricted stock (as governed by the Company’s 2004 Equity Incentive Plan (the “Plan”)) to the
Grantee described herein has been approved by the Company’s Compensation Committee. 
  
 NOW, THEREFORE, pursuant to the Plan, the Company, upon the terms and conditions set forth herein, hereby grants to you              restricted shares
of Common Stock, par value $.0001, (“Common Stock”) of the Company (the “Restricted Shares”) effective as of the date hereof (the “Date of Grant”), and subject to the terms and conditions of the
Plan and the terms and conditions of this Agreement. 
  
 1.
Definitions. All capitalized terms used herein and not otherwise defined herein shall have the meanings assigned to them in the Plan. 
  
 2. Issuance of Shares. In consideration of the Grantee’s service as an employee of the Company, the Restricted Shares shall be issued to the
Grantee, and, upon payment to the Company by the Grantee of the aggregate par value thereof, which payment shall be made within 10 days of the date hereof, shall be fully paid and nonassessable and shall be represented by a certificate or
certificates issued in the name of the Grantee and endorsed with an appropriate legend referring to the restrictions hereinafter set forth. 
  
 3. Restrictions on Transfer of Shares. The Restricted Shares may not be sold, assigned, transferred, conveyed, pledged, exchanged or otherwise
encumbered or disposed of (each, a “Transfer”) by the Grantee, except to the Company, unless and until they have become nonforfeitable as provided in Section 4 hereof. Any purported encumbrance or disposition in violation of the
provisions of this Section 3 shall be void AB INITIO, and the other party to any such purported transaction shall not obtain any rights to or interest in the Restricted Shares. As and when permitted by the Plan, the Committee may in its sole
discretion waive the restrictions on transferability with respect to all or a portion of the Restricted Shares. Notwithstanding the foregoing, Grantee may not Transfer Restricted Shares which have become nonforfeitable as provided in Section 4
hereof unless such Restricted Shares are registered pursuant to the Securities Act of 1933 (the “Securities Act”), are sold under Rule 144 promulgated under the Securities Act or unless the Company, after consultation with counsel,
and its counsel agree with Grantee that such Transfer is not required to be registered under the Securities Act. 

 4. Vesting of Shares. 
  
 (a) Subject to paragraph (b) below and Section 5 hereof, the Restricted Shares shall vest and become nonforfeitable if the
Grantee remains an employee of the Company through the last day of the fiscal year relating to calendar year 2008. 
  
 (b) Notwithstanding the provisions of Section 4(a) above, the Restricted Shares shall vest and become nonforfeitable as set forth in Section 4(a) above on
the vesting date only if the Company achieves: (i) an aggregate amount of Operating Income for the fiscal years relating to calendar years 2005, 2005, 2007 and 2008, at least equal to (ii) the aggregate amount of Minimum Operating Income for such
four fiscal years. For purposes of the Section 4, “Operating Income” shall mean, with respect to any Person(s) for any period, the earnings of such Person(s) for such period before interest and taxes for such period, determined on a
consolidated basis in accordance with United States generally accepted accounting principles as in effect from time to time. “Minimum Operating Income” shall mean, with respect to any fiscal year, targeted Operating Income with
respect to such fiscal year as such targeted Operating Income is (A) determined in accordance with the Company’s budgeting and forecast procedures, and (B) approved by the Committee. Determinations and interpretations of the Committee on all
matters relating to the Plan and this Agreement, including determinations and interpretations with respect to Operating Income and Minimum Operating Income, shall be in the Committee’s sole discretion and shall be conclusive and binding on the
Grantee and the Company. 
  
 (c) Notwithstanding the provisions of
Section 4(a) above, in connection with a Change in Control, the provisions set forth in Section 13 of the Plan shall govern with respect to the acceleration of the vesting of the Restricted Shares. 
  
 (d) Notwithstanding the provisions of Section 4(a) or 4(b) above, the
Committee may, in its sole discretion, vest or accelerate the vesting of shares of the Restricted Shares at any time. 
  
 5. Forfeiture of Shares. If the Grantee ceases to be an employee of the Company due to death or Disability during any period of restriction, any
non-vested Restricted Shares shall immediately vest and all restrictions on the Restricted Shares shall lapse and certificate(s) representing such Restricted Shares shall be delivered by the Company reasonably promptly upon a request by the Grantee.
If the Grantee ceases to be an employee of the Company for any other reason, any non-vested Restricted Shares shall be forfeited by the Grantee and the certificate(s) representing the non-vested portion of the Restricted Shares so forfeited shall be
canceled. 
  
 6. Dividend, Voting and Other Rights. Except
as otherwise provided in this Agreement, from and after the Date of Grant, the Grantee shall have all of the rights of a stockholder with respect to the Restricted Shares, including the right to vote the Restricted Shares and receive any dividends
that may be paid thereto, provided, however, that any additional Common Stock or other securities that the Grantee may become entitled to receive pursuant to a stock dividend, stock split, recapitalization, combination of shares, merger,
consolidation, separation or reorganization or any other change in the capital structure of the Company shall be subject to the same risk of forfeiture, certificate delivery provisions and restrictions on transfer as the forfeitable Restricted
Shares in respect of which they are issued or transferred and shall become Restricted Shares for the purposes of this Agreement. 
  

 2 

 7. Retention of Stock Certificate(s) by the Company. The certificate(s) representing the
Restricted Shares shall be held in custody by the Company, together with a stock power in the form of Exhibit A hereto which shall be endorsed in blank by the Grantee and delivered to the Company within 10 days of the date hereof, until such shares
have become nonforfeitable in accordance with Section 4. 
  
 8.
Compliance with Law. The Company shall make reasonable efforts to comply with all applicable federal and state securities laws, provided, however, notwithstanding any other provision of this Agreement, the Company shall not be obligated to
issue or release from restrictions on transfer any Restricted Shares pursuant to this Agreement if such issuance or release would result in a violation of any such law. 
  
 9. Withholding Taxes. If the Company shall be required to withhold any federal, state, local or foreign tax in
connection with any issuance or vesting of Restricted Shares or other securities pursuant to this Agreement, and the amounts available to the Company for such withholding are insufficient, the Grantee shall pay the tax or make provisions that are
satisfactory to the Company for the payment thereof. The Grantee may elect to satisfy all or any part of any such withholding obligation by surrendering to the Company a portion of the Restricted Shares that become nonforfeitable hereunder, and the
Restricted Shares so surrendered by the Grantee shall be credited against any such withholding obligation at the market value (determined with reference to the then current price of the Company’s Common Stock as quoted on the New York Stock
Exchange) per Share of such Restricted Shares on the date of such surrender. 
  
 10. Conformity with Plan. The Agreement and the Restricted Shares granted pursuant hereto are intended to conform in all respects with, and are subject to all applicable provisions of, the Plan (which is
incorporated herein by reference). Inconsistencies between this letter agreement and the Plan shall be resolved in accordance with the terms of the Plan. By executing this Agreement, you acknowledge and agree to be bound by all of the terms of this
Agreement and the Plan. 
  
 11. Amendments. The provisions
of this Agreement may be amended and waived only with the prior written consent of the Company and the Grantee. 
  
 12. Severability. In the event that one or more of the provisions of this Agreement shall be invalidated for any reason by a court of competent
jurisdiction, any provision so invalidated shall be deemed to be separable from the other provisions hereof, and the remaining provisions hereof shall continue to be valid and fully enforceable. 
  
 13. Successors and Assigns. The provisions of this Agreement shall
inure to the benefit of, and be binding upon, the successors, administrators, heirs, legal representatives and assigns of the Grantee and the successors and assigns of the Company. 
  
 14. Notices. Any notice to the Company provided for herein shall be in writing to the attention of the Secretary of
the Company at Symmetry Medical Inc., 220 W. Market Street, Warsaw, Indiana 46580, and any notice to the Grantee shall be addressed to the Grantee at his address currently on file with the Company. Except as otherwise provided herein, any written

  

 3 

 
notice shall be deemed to be duly given if and when hand delivered, or five business days after having been mailed by United States registered or certified
mail, return receipt requested, postage prepaid, or three business days after having been sent by a nationally recognized overnight courier service, addressed as aforesaid. Any party may change the address to which notices are to be given hereunder
by written notice to the other party as herein specified, except that notices of changes of address shall be effective only upon receipt. 
  
 15. Governing Law. The laws of the State of New York, without giving effect to the principles of conflict of laws thereof, shall govern the
interpretation, performance and enforcement of this Agreement. 
  
 * * * * * 
  

 4 

 IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first set forth above.

  

			
	SYMMETRY MEDICAL INC.
		
	 By:
	 	  

	 Name:
	 	  

	 Title:
	 	  

  

	
	ACKNOWLEDGED AND AGREED:
	
	  

	 (Signature of Grantee)

  

 5 

 EXHIBIT A 
  

FORM OF ASSIGNMENT SEPARATE FROM CERTIFICATE 
  
 FOR VALUE RECEIVED,
                     hereby sells, assigns and transfers unto
                    ,              shares of the Common Stock, par value
$0.001 per share, of Symmetry Medical Inc., a Delaware corporation (the “Company”) standing in its name on the books of said Company represented by Certificate Number
            , and does hereby irrevocably constitute and appoint
                     as attorney to transfer the said stock on the books of the Company with full power of substitution in the premises.

  

					
	 Date:
                    
	 	 	 	  

 Holder

  

 6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00084-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00084-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00084-of-00352.parquet"}]]